PharmaCyte Biotech Inc (PMCB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.77M
Last updated: Nov 17, 2026 at 11:05 AM ET
PharmaCyte Biotech Inc (PMCB) Earnings: Report Dates and Results
PharmaCyte Biotech (PMCB) is expected to report earnings on Dec 16, 2026. In the quarter ended Jul 31, 2026, PharmaCyte Biotech reported EPS of -$0.54. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
PMCB has an expected report date of Dec 16, 2026.
Earnings History
Of the 11 quarters below that had an estimate, PMCB beat 4, missed 4 and matched 3. The widest gap in the table came in the quarter ended Jul 31, 2023, when EPS landed 297.14% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | -$0.54 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 14, 2026 |
| Apr 30, 2026 | -$0.01 | N/A | N/A | N/A | N/A | -100.6% | N/A | N/A | Jul 1, 2026 |
| Jan 31, 2026 | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 17, 2026 |
| Oct 31, 2025 | -$1.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 18, 2025 |
| Jul 31, 2025 | -$1.23 | N/A | N/A | N/A | N/A | -164.7% | N/A | N/A | Aug 11, 2025 |
| Apr 30, 2025 | $1.58 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 2, 2025 |
| Jan 31, 2025 | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 17, 2025 |
| Oct 31, 2024 | -$0.39 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 13, 2024 |
| Jul 31, 2024 | $1.90 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Aug 13, 2024 |
| Apr 30, 2024 | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 29, 2024 |
| Jan 31, 2024 | -$0.07 | -$0.07 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Mar 18, 2024 |
| Oct 31, 2023 | -$0.26 | -$0.08 | N/A | -222.00% | Miss | N/A | N/A | 0 up, 0 down | Dec 15, 2023 |
| Jul 31, 2023 | -$0.28 | -$0.07 | N/A | -297.14% | Miss | N/A | N/A | 0 up, 0 down | Sep 18, 2023 |
| Apr 30, 2023 | -$0.01 | -$0.09 | N/A | +91.67% | Beat | N/A | N/A | 0 up, 0 down | Jul 31, 2023 |
| Jan 31, 2023 | -$0.04 | -$0.08 | N/A | +49.75% | Beat | N/A | N/A | 0 up, 0 down | Mar 16, 2023 |
| Oct 31, 2022 | -$0.09 | -$0.08 | N/A | -14.25% | Miss | N/A | N/A | 0 up, 0 down | Dec 14, 2022 |
| Jul 31, 2022 | -$0.07 | -$0.07 | -$0.07 - -$0.07 | 0.00% | In line | N/A | 1 | 0 up, 0 down | Sep 14, 2022 |
| Apr 30, 2022 | -$0.06 | -$0.04 | -$0.04 - -$0.04 | -50.00% | Miss | N/A | 1 | 0 up, 0 down | Jul 28, 2022 |
| Jan 31, 2022 | -$0.04 | -$0.05 | -$0.05 - -$0.05 | +20.00% | Beat | N/A | 1 | 0 up, 0 down | Mar 15, 2022 |
| Oct 31, 2021 | -$0.06 | -$0.07 | N/A | +14.29% | Beat | N/A | N/A | N/A | Dec 14, 2021 |
| Jul 31, 2021 | -$0.64 | -$0.64 | N/A | 0.00% | In line | N/A | N/A | N/A | Aug 10, 2021 |
| Apr 30, 2021 | -$0.64 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2021 |
| Jan 31, 2021 | -$0.61 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 12, 2021 |
| Oct 31, 2020 | -$0.49 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 11, 2020 |
| Jul 31, 2020 | -$0.62 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2020 |
| Apr 30, 2020 | -$0.79 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 1, 2020 |
| Jan 31, 2020 | -$0.72 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 13, 2020 |
| Oct 31, 2019 | -$0.95 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 23, 2019 |
| Jul 31, 2019 | -$1.21 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 12, 2019 |
| Apr 30, 2019 | -$1.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 3, 2019 |
| Jan 31, 2019 | -$1.49 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 14, 2019 |
| Oct 31, 2018 | -$0.90 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 14, 2018 |
| Jul 31, 2018 | -$1.44 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 12, 2018 |
| Apr 30, 2018 | -$1.74 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 20, 2018 |
| Jan 31, 2018 | -$1.94 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 19, 2018 |
| Oct 31, 2017 | -$3.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 14, 2017 |
| Jul 31, 2017 | -$2.80 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 13, 2017 |
| Apr 30, 2017 | -$2.74 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 27, 2017 |
| Jan 31, 2017 | -$8.76 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 13, 2017 |
| Oct 31, 2016 | -$2.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 2, 2016 |
Annual EPS
EPS for the fiscal year ended Apr 30, 2026 was -$2.65, after $2.66 the year before. It was -$15.45 for the year ended Apr 30, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Apr 30, 2026 | -$2.65 | -199.7% |
| Apr 30, 2025 | $2.66 | N/A |
| Apr 30, 2024 | -$0.92 | N/A |
| Apr 30, 2023 | -$0.21 | N/A |
| Apr 30, 2022 | -$0.80 | N/A |
| Apr 30, 2021 | -$2.36 | N/A |
| Apr 30, 2020 | -$3.67 | N/A |
| Apr 30, 2019 | -$5.23 | N/A |
| Apr 30, 2018 | -$9.60 | N/A |
| Apr 30, 2017 | -$15.45 | N/A |
Frequently Asked Questions About PMCB
When is PharmaCyte Biotech's next earnings date?
PharmaCyte Biotech's next earnings report is expected for Dec 16, 2026.
How often does PMCB beat earnings estimates?
PharmaCyte Biotech beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -55.25%.
PMCB pages: Overview, Earnings, Financials, Competitors